Osteoporosis and gut microbiota, radiofrequency echographic multispectrometry and machine learning: one year in review 2023

Maffi, M.; Mattia, Gianmarco De; Mazzantini, M

doi:10.55563/clinexprheumatol/ma4l1t

Cited by 1 publication

(1 citation statement)

References 51 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Following our regular annual reviews on different aspects of rheumatology (5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15) we will here provide a critical digest of the recent literature on Ax-SpA of 2021 and 2022 (Medline search of articles published from 1st January 2021 to 31th December 2022). In particular, we performed an on-line search on MESH database, using as key terms "blood", "chemistry", "diagnosis", "diagnostic imaging", "drug therapy", "epidemiology", "metabolism",…”

Section: Methodsmentioning

confidence: 99%

Axial spondyloarthritis: one year in review 2023

Fattorini,

Gentileschi,

Cigolini

et al. 2023

Clinical and Experimental Rheumatology

View full text Add to dashboard Cite

Axial spondyloarthritides (axSpA) are a group of systemic autoimmune diseases, characterised by an inflammatory involvement of the axial skeleton, which, in the earlier phases, cannot be detected by conventional radiology, but only by magnetic resonance imaging, thus defining the so-called non-radiographic axSpA (nr-axSpA). The initial osteitis then tends to complicate into bone reabsorption and aberrant bone deposition, which then determines the ankylosis of the axial skeleton in the latest phases of the disease. Peripheral joints may also be affected, enthesitis being its more characteristic manifestation. The radiographic form corresponds to ankylosing spondylitis which, with psoriatic arthritis, is the best-known subtype of SpA. AxSpA are rarely associated to laboratory abnormalities and are usually complicated by the presence of both extra-articular manifestations (particularly acute anterior uveitis, psoriasis and inflamatory bowel disease) and comorbidities, with a subsequent higher risk for patients of an impaired quality of life. In this paper we reviewed the literature on axSpA of 2021 and 2022 (Medline search of articles published from 1st January 2021 to 31st December 2022).

show abstract